Literature DB >> 16351589

Significantly reduced salivary nitric oxide synthesis in patients with Parkinson's disease.

Jasminko Huskić1, Alma Paperniku, Azra Husić, Faruk Alendar, Nedzad Mulabegović.   

Abstract

In order to study concentration of nitric oxide (NO) in the saliva of patients with Parkinson's disease (PD), we measured the concentration of its stable metabolite nitrite (NO(2)-) in the saliva of these patients and healthy subjects. We analyzed saliva flow rate and salivary NO concentrations in 16 subjects with Parkinson's disease and in 16 healthy subjects. Concentration of nitrite was determined by colorimetric method using Griess reaction. Saliva flow rate was significantly lower in patients with Parkinson's disease (0.2+/-0.03 mL/min; X+/-SEM) than in healthy subjects. Salivary NO(2)-concentration was significantly lower (5.02+/-0.64) than in healthy individuals (22.39+/-1.24, p<0.0001).

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16351589      PMCID: PMC7202145          DOI: 10.17305/bjbms.2005.3277

Source DB:  PubMed          Journal:  Bosn J Basic Med Sci        ISSN: 1512-8601            Impact factor:   3.363


  15 in total

1.  A study of salivary secretion in Parkinson's disease.

Authors:  H Bagheri; C Damase-Michel; M Lapeyre-Mestre; S Cismondo; D O'Connell; J M Senard; O Rascol; J L Montastruc
Journal:  Clin Neuropharmacol       Date:  1999 Jul-Aug       Impact factor: 1.592

2.  Nitric oxide synthesis is decreased in periodontitis.

Authors:  A Aurer; J Aleksić; M Ivić-Kardum; J Aurer; F Culo
Journal:  J Clin Periodontol       Date:  2001-06       Impact factor: 8.728

3.  [The investigation on nitric oxide levels in saliva and their relationship with the severity of periodontitis].

Authors:  G Chen; W Sun
Journal:  Hua Xi Kou Qiang Yi Xue Za Zhi       Date:  1999-05

Review 4.  Nitric oxide: physiology, pathophysiology, and pharmacology.

Authors:  S Moncada; R M Palmer; E A Higgs
Journal:  Pharmacol Rev       Date:  1991-06       Impact factor: 25.468

5.  [The stimulation of nitric oxide synthesis as a possible protective function of the saliva and its disorders in periodontal diseases].

Authors:  A L Kankanian; S E Akopov
Journal:  Stomatologiia (Mosk)       Date:  1996

6.  Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids.

Authors:  L C Green; D A Wagner; J Glogowski; P L Skipper; J S Wishnok; S R Tannenbaum
Journal:  Anal Biochem       Date:  1982-10       Impact factor: 3.365

7.  Salivary production in Parkinson's disease.

Authors:  Melisa Proulx; François P de Courval; Michael A Wiseman; Michel Panisset
Journal:  Mov Disord       Date:  2005-02       Impact factor: 10.338

8.  Double-blind, placebo-controlled study to evaluate the efficacy and safety of botulinum toxin type A in the treatment of drooling in parkinsonism.

Authors:  Francesca Mancini; Roberta Zangaglia; Silvano Cristina; Maria Grazia Sommaruga; Emilia Martignoni; Giuseppe Nappi; Claudio Pacchetti
Journal:  Mov Disord       Date:  2003-06       Impact factor: 10.338

9.  Influence of Parkinson's disease on oral health.

Authors:  M Persson; T Osterberg; A K Granérus; S Karlsson
Journal:  Acta Odontol Scand       Date:  1992-02       Impact factor: 2.331

10.  Significantly reduced salivary nitric oxide levels in smokers.

Authors:  S Bodis; A Haregewoin
Journal:  Ann Oncol       Date:  1994-04       Impact factor: 32.976

View more
  4 in total

1.  Excessive levels of nitric oxide in rat model of Parkinson's disease induced by rotenone.

Authors:  Zhong-Kui Xiong; Juan Lang; Gang Xu; Hai-Yu Li; Yun Zhang; Lei Wang; Yao Su; Ai-Jing Sun
Journal:  Exp Ther Med       Date:  2014-12-02       Impact factor: 2.447

2.  Iron and Oxidative Stress in Parkinson's Disease: An Observational Study of Injury Biomarkers.

Authors:  Marcio S Medeiros; Arthur Schumacher-Schuh; Andreia Machado Cardoso; Guilherme Vargas Bochi; Jucimara Baldissarelli; Aline Kegler; Daniel Santana; Carolina Maria Martins Behle Soares Chaves; Maria Rosa Chitolina Schetinger; Rafael Noal Moresco; Carlos R M Rieder; Michele Rechia Fighera
Journal:  PLoS One       Date:  2016-01-11       Impact factor: 3.240

3.  Significance of Nitric Oxyde Saliva Concentration of the Patients with Renal Failure on Hemodialysis.

Authors:  Marina Vucijak-Grgurevic; Faris Zvizdic; Azra Durak-Nalbantic; Elmedina Jahic; Nerma Resic; Jasminko Huskic
Journal:  Mater Sociomed       Date:  2018-12

4.  Serum insulin-like growth factor-1 and nitric oxide levels in Parkinson's disease.

Authors:  Deniz Tuncel; Fatma Inanc Tolun; Ismail Toru
Journal:  Mediators Inflamm       Date:  2009-03-12       Impact factor: 4.711

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.